Authorized purpose: Parallel worklist triage for suspected vertebral compression fractures in patients aged 50 years and over within the standard-of-care bone-health setting; not a diagnostic device
Clinical role
Parallel triage/notification application that flags suspected VCF cases without altering original images or removing cases from the standard worklist
Images and patients
CT/CTA · Thoracic and lumbar vertebrae T1-L5 within chest and/or abdomen CT
Key limitation
Keep in mind: Not intended for diagnosis; preview is informational and not diagnostic; clinician must review the full study using standard of care; the device operates in parallel and does not alter original images or remove cases from the worklist
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Parallel worklist triage for suspected vertebral compression fractures in patients aged 50 years and over within the standard-of-care bone-health setting; not a diagnostic device
Which images or clinical context are in scope?Modality: CT/CTA Anatomy or clinical context: Thoracic and lumbar vertebrae T1-L5 within chest and/or abdomen CT Input: DICOM non-enhanced or contrast-enhanced CT of the chest and/or abdomen in patients aged 50 years and over, including at least three consecutive measurable vertebrae in the T1-L5 portion of the spine
Who uses it?Intended users: Hospital networks and appropriately trained medical specialists within the standard-of-care bone-health setting
What does the software produce?Output: Worklist icon/flag for suspected VCF at T1-L5 and a compressed grayscale unannotated preview marked not for diagnostic use; results are transferred to PACS or a workstation for prioritization and the full original study remains required
What is its most important limitation?Key limitation: Not intended for diagnosis; preview is informational and not diagnostic; clinician must review the full study using standard of care; the device operates in parallel and does not alter original images or remove cases from the worklist
Clinical takeaway. Clinical role: Parallel worklist triage for suspected vertebral compression fractures in patients aged 50 years and over within the standard-of-care bone-health setting; not a diagnostic device
Evidence takeaway. Evidence from the reviewed source record: Retrospective multicenter, multinational, blinded study used 474 cases, 180 positive and 294 negative, with ground truth by consensus of three US-board-certified expert radiologists. Primary endpoint ROC AUC was 0.974 (95% CI 0.962-0.986) against a 0.95 performance goal. Additional sensitivity was 95.2% (90.7%-97.9%), specificity 92.9% (89.4%-96.5%), and accuracy 93.7% (91.1%-95.7%). Mean time-to-notification was 23.4 seconds for all cases and 21.7 seconds for 158 true-positive cases
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Parallel worklist triage for suspected vertebral compression fractures in patients aged 50 years and over within the standard-of-care bone-health setting; not a diagnostic device
DICOM non-enhanced or contrast-enhanced CT of the chest and/or abdomen in patients aged 50 years and over, including at least three consecutive measurable vertebrae in the T1-L5 portion of the spine
Worklist icon/flag for suspected VCF at T1-L5 and a compressed grayscale unannotated preview marked not for diagnostic use; results are transferred to PACS or a workstation for prioritization and the full original study remains required
Not intended for diagnosis; preview is informational and not diagnostic; clinician must review the full study using standard of care; the device operates in parallel and does not alter original images or remove cases from the worklist
Retrospective multicenter, multinational, blinded study used 474 cases, 180 positive and 294 negative, with ground truth by consensus of three US-board-certified expert radiologists. Primary endpoint ROC AUC was 0.974 (95% CI 0.962-0.986) against a 0.95 performance goal. Additional sensitivity was 95.2% (90.7%-97.9%), specificity 92.9% (89.4%-96.5%), and accuracy 93.7% (91.1%-95.7%). Mean time-to-notification was 23.4 seconds for all cases and 21.7 seconds for 158 true-positive cases
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
Retrospective multicenter, multinational, blinded study used 474 cases, 180 positive and 294 negative, with ground truth by consensus of three US-board-certified expert radiologists. Primary endpoint ROC AUC was 0.974 (95% CI 0.962-0.986) against a 0.95 performance goal. Additional sensitivity was 95.2% (90.7%-97.9%), specificity 92.9% (89.4%-96.5%), and accuracy 93.7% (91.1%-95.7%). Mean time-to-notification was 23.4 seconds for all cases and 21.7 seconds for 158 true-positive cases
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
CINA-VCF regulatory performance study summary
DesignStand-Alone Performance
PopulationAdult
Scopeexact submission
Tested versionExact product version not reported; regulatory study summarized for FDA submission K240612
Samplen=474
IndependenceIndependence not established
K240612
ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K240612. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: DICOM non-enhanced or contrast-enhanced CT of the chest and/or abdomen in patients aged 50 years and over, including at least three consecutive measurable vertebrae in the T1-L5 portion of the spine
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: VCF Image Processing Application can be used with the CINA Platform cleared under K200855 or another compatible medical image communications device. DICOM services connect CT modalities or other DICOM nodes such as routers and PACS, with a Worklist client receiving notifications; exact local versions are not established
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Source context, not route validation: The exact FDA package describes CINA-VCF as running on a standard off-the-shelf server/workstation, with its VCF Image Processing Application integrated, deployed and used with the CINA Platform (K200855) or other compatible medical image communications devices. Current hosting, data flow, and commercial configuration require vendor confirmation.
Scope: Exact FDA submission. Packet wording: "CINA-VCF runs on a standard “off the shelf” server/workstation and consists of VCF Image Processing" … "Application, which can be integrated, deployed and used with the CINA Platform (cleared under K200855) or other compatible medical image communications devices.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Source context, not route validation: Worklist icon/flag for suspected VCF at T1-L5 and a compressed grayscale unannotated preview marked not for diagnostic use; results are transferred to PACS or a workstation for prioritization and the full original study remains required
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: Worklist icon/flag for suspected VCF at T1-L5 and a compressed grayscale unannotated preview marked not for diagnostic use; results are transferred to PACS or a workstation for prioritization and the full original study remains required
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The exact FDA package describes CINA-VCF as running on a standard off-the-shelf server/workstation, with its VCF Image Processing Application integrated, deployed and used with the CINA Platform (K200855) or other compatible medical image communications devices. Current hosting, data flow, and commercial configuration require vendor confirmation.
Exact FDA submission
Checked 2026-11-14
Packet wording: "CINA-VCF runs on a standard “off the shelf” server/workstation and consists of VCF Image Processing" … "Application, which can be integrated, deployed and used with the CINA Platform (cleared under K200855) or other compatible medical image communications devices.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
VCF Image Processing Application can be used with the CINA Platform cleared under K200855 or another compatible medical image communications device. DICOM services connect CT modalities or other DICOM nodes such as routers and PACS, with a Worklist client receiving notifications; exact local versions are not established
Avicenna.AI's cybersecurity page states ISO/IEC 27001 certification by SGS, IEC 81001-5-1, TLS 1.2+ in transit, encryption at rest, role-based access with least privilege, and a HIPAA business associate agreement for US customers. Vendor-wide.
Vendor-wide
Checked 2026-10-25
Vendor statement, not an attestation; exact-release scope is not established.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
25Fields reviewed
10Source classes checked
1Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains 1 PubMed and 0 ClinicalTrials.gov candidate record. Discovery metadata alone does not establish exact tested-product, version, population, and endpoint applicability, so all candidates remain quarantined and none was promoted. The current discovery snapshot contains 1 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, vendor documentation, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-09-08 - Exact FDA submission
No public price or quote for the exact K240612 configuration was established in this review.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-09-08 - Exact FDA submission
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-09-08 - Exact FDA submission
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Monitoring: Not verified - checked 2026-09-08 - Exact FDA submission
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
Authorized purpose: BriefCase-Triage CARE Multi-Triage CT analyzes contrast and non-contrast chest, abdomen, or chest/abdomen CT in adults or transitional adolescents aged 18 and older to flag suspected pneumothorax, pericardial effusion, large aortic aneurysm, or shoulder fracture/dislocation for hospital-network workflow triage; notifications and previews are for prioritization, not diagnosis.
Modality
CT/CTA
Anatomy
Chest and abdomen; pneumothorax, pericardial effusion, large aortic aneurysm, and shoulder fracture/dislocation
Authorized purpose: Workflow triage and notification of suspect cases with three or more acute rib-fracture (RibFx) pathologies in adults or transitional adolescents aged 18 and older.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.